VIVA

This channel contains news about the annual Vascular Interventional Advances (VIVA) conference. VIVA is a premier conference for new techniques and technologies to treat vascular disease. This includes the areas of peripheral artery disease (PAD), critical limb ischemia (CLI), endovascular repair and venous therapies.

Clinical study evaluates treatment for endovascular aortic arch repair

News | Endovascular Aortic Repair

UH Harrington Heart and Vascular Institute Performs First TRIOMPHE Study Case in Northeast Ohio

October 26, 2022 — Thousands of people have new hope for treatment of thoracic aortic arch disease and University ...

October 26, 2022

Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA (Vascular InterVentional Advances) Annual Conference, Oct. 30-Nov. 3, 2022, have been announced.

News | Cardiovascular Education

Late-breaking Clinical Trial presentations announced for The VEINS and VIVA Conference

September 14, 2022 — Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INte ...

September 14, 2022

Philips, a global leader in health technology and IVUS solutions, announced that a worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions

News | Intra-Vascular Ultrasound (IVUS)

First-ever Global Consensus for the Appropriate Use of IVUS in Peripheral Vascular Disease Interventions

October 20, 2021 — Philips, a global leader in health technology and intravascular ultrasound (IVUS) solutions ...

October 20, 2021

The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, for the treatment of long tibial occlusive lesions (TASC C & D) in patients with Critical Limb Ischemia (CLI). It was presented at VIVA 2021.

News | Drug-Eluting Balloons

18-Month Below-the-Knee Data With MedAlliance’s SELUTION SLR Presented at VIVA

October 20, 2021 — 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a late-breaking ...

October 20, 2021

the Eluvia stent exhibited superiority with a primary patency rate of 85.4% versus 76.3% with BMS (p=0.0077).1 The analysis also confirmed a significantly greater rate of sustained clinical improvement without reintervention

News | Peripheral Artery Disease (PAD)

Boston Scientific Eluvia Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal Stents

October 20, 2021 — Boston Scientific Corporation announced positive data for the Eluvia Drug-Eluting Vascular Stent ...

October 20, 2021

A lone vendor booth in a sea of open space in a corner of the expo floor at HIMSS 2021 this week. A large number of vendors decided to pull out of exhibiting at HIMSS in recent weeks because the host city of Las Vegas saw a major surge of COVID cases over July, reaching a 20.2% positivity rate on the day HIMSS began.

Blog | Coronavirus (COVID-19)

HIMSS 2021 Showed What to Expect From In-person Healthcare Conferences During the COVID Pandemic

The in-person 2021 Healthcare Information Management Systems Society (HIMSS) meeting planned for Aug. 9-13 appeared to ...

August 13, 2021

News | VIVA

The Latest Vascular Interventional Clinical Data Presented at VIVA 2020

October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical ...

October 05, 2020

The ClotTriever system (Inari Medical), a mechanical thrombectomy system FDA 510(k) cleared for the nonsurgical removal of soft thrombi and emboli from peripheral blood vessels. #VIVA19 #VIVA2019

News | Deep Vein Thrombosis (DVT)

DVT ClotTriever (CLOUT) Registry Shows Significant Improvement

November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...

November 14, 2019

News | Peripheral Artery Disease (PAD)

The ULYSSE Registry Shows Benefit of Ultrasoundplasty Before Below-the-knee Interventions

November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

November 14, 2019

News | Peripheral Artery Disease (PAD)

Adventitial Temsirolimus Injections in BTK Lesions Improved Outcomes in TANGO Trial

November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...

November 14, 2019

The LimFlow procedure permanently bypasses unreconstructable arteries and leverages healthier veins as a conduit to create new routes to perfuse tissue in the foot. #VIVA #VIVA19 #VIVA2019

News | Peripheral Artery Disease (PAD)

LimFlow Procedure Successful in Bypassing Unreconstructable Arteries in Limb-threatening Ischemia

November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...

November 14, 2019

The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the Medtronic IN.PACT AV Access drug-coated balloon (DCB) met both of its endpoints, in data presented at the 2019 Vascular Interventional Advances (VIVA) annual meeting. #VIVA #VIVA19 #VIVA2019

News | Drug-Eluting Balloons

IN.PACT AV Access 6-Month Data Show Increased Vessel Patency

November 7, 2019 — The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...

November 14, 2019

The Rex Medical Revolution rotational atherectomy system incorporates continuous aspiration and has a dual indication for atherectomy and thrombectomy. #VICA19 #VIVA2019

News | Atherectomy Devices

Revolution Rotational Atherectomy System Effective in IDE Experience

November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

November 11, 2019

The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for endovascular treatment of pathologies extending or involving the aortic arch. #VIVA19 #VIVA2019

News | Endovascular Aortic Repair

Nexus Arch Branch Stent Graft System Shows Positive Mid-term Results

November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...

November 11, 2019

The repuncturable Supera vascular mimetic peripheral stent system from Abbott Vascular was shown to manage bulky, heavily calcified CFA disease due to its extreme crush resistance in the VMI-CFA study. #VIVA #VIVA19 #VIVA2019

News | Stents Carotid

Supera Safe to use for Femoral Stenting Versus Surgery in VMI-CFA Trial

November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...

November 11, 2019